pGDP2 MCR-1 Citations (2)

Originally described in: A Common Platform for Antibiotic Dereplication and Adjuvant Discovery.
Cox G, Sieron A, King AM, De Pascale G, Pawlowski AC, Koteva K, Wright GD Cell Chem Biol. 2017 Jan 19;24(1):98-109. doi: 10.1016/j.chembiol.2016.11.011. Epub 2016 Dec 22. PubMed Journal

---

Articles Citing pGDP2 MCR-1

Articles
Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens. Wesseling CMJ, Slingerland CJ, Veraar S, Lok S, Martin NI. ACS Infect Dis. 2021 Dec 10;7(12):3314-3335. doi: 10.1021/acsinfecdis.1c00466. Epub 2021 Nov 12. PubMed
Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin. Lim AL, Miller BW, Lin Z, Fisher MA, Barrows LR, Haygood MG, Schmidt EW. Microbiol Spectr. 2023 Dec 12;11(6):e0230623. doi: 10.1128/spectrum.02306-23. Epub 2023 Oct 26. PubMed

If you have published an article using this material, please email us at to have your article added to this page.